ResearcherJacobio Pharmaceuticals Co., Ltd.Active in the last 2 years

Jacobio Pharmaceuticals

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 2
Grants: 0
Labs led: 0
Collaborators: 0

Papers, trials and grants by year

2019: 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 trial

Trials 2

Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations Study director NCT07640295 ↗
A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors Study director NCT04045496 ↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.